Skip to main content

Concord Wealth Partners

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1814214 ABINGDON, VA

Position in AGIO

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$7,422
+$1,978 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#209
of 236 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Concord Wealth Partners holds $158,287 across 14 Biotechnology names. AGIO ranks #3 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 AGIO
Agios Pharmaceuticals, Inc.
This page
200 $7,422

All Filings in AGIO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,422 200
2025-12-31 $5,444 200
2025-09-30 $8,028 200
2025-06-30 $6,652 200
2025-03-31 $5,860 200
2024-12-31 $6,572 200
2024-09-30 $8,886 200
2024-06-30 $8,624 200
2024-03-31 $5,848 200
2023-12-31 $4,454 200
2023-09-30 $4,950 200
2023-06-30 $5,664 200
2023-03-31 $4,594 200
2022-12-31 $5,616 200
2022-06-30 $4,434 200
2022-03-31 $5,822 200
2021-12-31 $6,574 200